Resmed RMD
NYSE RMD
$224.99 -3.51 (-1.54%)
At close: Sep 18, 2026 · 4:00 PM EDT

Resmed (RMD) Net Margin Growth (1y) (2010 - 2026)

Analysis

Resmed (RMD) Net Margin Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Abbott Laboratories 177.43 Bn 172.48 Bn 7.27 Bn -860.00
2 Intuitive Surgical 139.20 Bn 134.11 Bn 1.96 Bn 124.00
3 Medtronic 118.01 Bn 109.81 Bn 6.34 Bn 296.00
4 Stryker 105.44 Bn 101.96 Bn 4.50 Bn 469.00
5 Boston Scientific 62.90 Bn 62.60 Bn 3.85 Bn 92.00
6 Edwards Lifesciences 50.87 Bn 46.72 Bn 1.35 Bn -777.00
7 Dexcom 33.72 Bn 31.77 Bn 830.00 Mn 350.00
8 Resmed 32.45 Bn 30.98 Bn 861.22 Mn -197.00
9 Alcon 31.70 Bn 30.25 Bn 1.68 Bn -
10 Steris 20.01 Bn 19.54 Bn 684.20 Mn 67.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -197.00
Mar 31, 2026 -40.00
Dec 31, 2025 71.00
Sep 30, 2025 67.00
Jun 30, 2025 428.00
Mar 31, 2025 316.00
Dec 31, 2024 892.00
Sep 30, 2024 552.00
Jun 30, 2024 342.00
Mar 31, 2024 429.00
Dec 31, 2023 -380.00
Sep 30, 2023 -224.00
Jun 30, 2023 -86.00
Mar 31, 2023 11.00
Dec 31, 2022 -79.00
Sep 30, 2022 -37.00
Jun 30, 2022 -94.00
Mar 31, 2022 3,092.00
Dec 31, 2021 11.00
Sep 30, 2021 -120.00